Photo Credit: USA TODAY NETWORK/IMAGN
Syndication: The State Journal-Register
NEW YORK—-(77WABC)
The FDA has authorized the controversial Baltimore Johnson and Johnson plant to ship more of their vaccines.
Earlier this year, regulators stopped the site from producing the vaccines over quality concerns.
However, the FDA just approved a batch of a few million vaccines to be shipped.
They’re still keeping an eye on the facility and haven’t given the full go-ahead.
More than 60 million doses have been rejected at the site.
Federal regulators on Friday cleared a batch of Johnson & Johnson’s one-shot coronavirus vaccine from the troubled Emergent plant in Baltimore. But J&J remains far from delivering on its goal of 100 million doses to the government by the end of June. https://t.co/THG3svrO2T
— The New York Times (@nytimes) July 2, 2021
